Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Clavulin is a combination antibiotic containing amoxicillin, a penicillin-type beta-lactam antibiotic, and clavulanic acid, a beta-lactamase inhibitor. It is used to treat a variety of bacterial infections by extending the spectrum of amoxicillin to include beta-lactamase-producing organisms. Clavulin is effective against respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain dental infections. The clavulanic acid component protects amoxicillin from degradation by beta-lactamase enzymes, restoring its efficacy against resistant bacterial strains.
Fact Table | |
Formula | C16H19N3O5S (amoxicillin) + C8H9NO5 (clavulanic acid) |
License | US FDA / Health Canada |
Bioavailability | Amoxicillin: ~95%; Clavulanic acid: ~60% (oral) |
Legal status | Prescription only |
Chemical Name | Amoxicillin and Clavulanic Acid |
Elimination half-life | Amoxicillin: 1–1.5 h; Clavulanic acid: ~1 h |
Dosage (Strength) | 250/125 mg, 500/125 mg, 875/125 mg tablets; oral suspension available |
Pregnancy | Category B – No evidence of risk in humans |
Brands | Clavulin, Augmentin, Co-amoxiclav, Curam, others |
Protein binding | Amoxicillin: ~20%; Clavulanic acid: ~25% |
PubChem CID | Amoxicillin: 33613; Clavulanic acid: 5280980 |
MedlinePlus | a685024 |
ChEBI | Amoxicillin: 2676; Clavulanic acid: 37531 |
ATC code | J01CR02 |
DrugBank | Amoxicillin: DB01060; Clavulanic acid: DB00766 |
KEGG | Amoxicillin: D07452; Clavulanic acid: D00210 |
Routes of administration | Oral, Intravenous |
Clavulin should be administered orally and is available in various formulations, including tablets, chewable tablets, and oral suspensions. Dosing depends on the severity and type of infection, as well as patient age and renal function. It is typically taken every 8 or 12 hours with food to minimize gastrointestinal upset. The tablet should be swallowed whole, and suspensions must be shaken well before use. Always follow the prescribing physician’s instructions precisely.
Active ingredients:
Inactive ingredients vary by formulation but may include: microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, sodium starch glycolate, and flavoring agents in suspensions.
Clavulin is contraindicated in patients with:
Use with caution in patients with hepatic impairment; monitor liver function tests during prolonged therapy. In patients with renal impairment, dosage adjustments are necessary. Severe allergic reactions, including anaphylaxis, have been reported. Clavulin should be discontinued if a skin rash or other signs of hypersensitivity appear. Pseudomembranous colitis has been reported with nearly all antibacterial agents, including Clavulin; evaluate patients presenting with diarrhea during or after treatment.
Common side effects may include:
Serious adverse effects may include hepatic dysfunction (elevated liver enzymes, hepatitis, cholestatic jaundice), severe allergic reactions, and Clostridioides difficile-associated diarrhea.